There was an increasing trend in the number of reports, with a slightly higher proportion of reports from women compared to men, and the primary reporting group was adults, especially those aged between 18 and 65 years.
← all excerpts
Data mining and analysis of adverse events of Vedolizumab based on the FAERS database.
1
—
—